Physician profile
Rachel B Griffin
NPI 1073951406
$2,441.74
in general payments reported to CMS, 2019-2025
34 companies · $529 in 2025
The $529 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,259 · 2022: $229 · 2023: $188 · 2024: $237 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $953.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $237.78 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Beta Bionics, INC. | $219.07 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Novo Nordisk INC | $217.26 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Sequel Med Tech, LLC | $201.76 | 2025 | Twiist |
| Abbott Laboratories | $161.00 | 2021-2022 | |
| Dexcom, INC. | $126.47 | 2021-2024 | Dexcom G6 Transmitter |
| Ibsa Pharma INC. | $125.59 | 2021-2025 | Tirosint, Licart, Flector |
| Insulet Corporation | $111.58 | 2021-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $91.83 | 2021-2024 | |
| Esperion Therapeutics, INC. | $80.78 | 2021-2022 | |
| Radius Health, INC. | $78.98 | 2021-2024 | |
| Abbvie INC. | $78.28 | 2021 | |
| Xeris Pharmaceuticals, INC. | $62.74 | 2021 | |
| Medtronic, INC. | $60.24 | 2021 | |
| Corcept Therapeutics | $57.41 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $50.97 | 2021 | |
| Amgen INC. | $44.65 | 2021-2025 | Repatha, Evenity |
| Boston Scientific Corporation | $42.84 | 2023 | |
| Zealand Pharma US, INC. | $42.77 | 2021 | |
| Tandem Diabetes Care, INC. | $40.52 | 2022 | |
| Currax Pharmaceuticals LLC | $38.93 | 2021 | |
| Lifescan, INC. | $36.49 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.90 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.13 | 2021 | |
| Nestle Healthcare Nutrition INC. | $20.56 | 2021 | |
| Alexion Pharmaceuticals, INC. | $19.10 | 2021 | |
| Becton, Dickinson and Company | $18.54 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.35 | 2021 | |
| Horizon Therapeutics Plc | $17.64 | 2021 | |
| Amneal Pharmaceuticals LLC | $16.14 | 2021 | |
| Vivus LLC | $14.69 | 2021 | |
| Amarin Pharma, INC. | $14.44 | 2021 | |
| Antares Pharma, INC. | $13.46 | 2021 | |
| Merck Sharp & Dohme LLC | $11.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.